Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/14676106

Clin. Cancer Res. 2003 Dec 1 9 16 Pt 1 5853-9

Download in:

View as

General Info

PMID
14676106